Growth Metrics

Innoviva (INVA) Receivables (2021 - 2026)

Innoviva filings provide 8 years of Receivables readings, the most recent being $93.3 million for Q4 2025.

  • On a quarterly basis, Receivables rose 8.05% to $93.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $93.3 million, a 8.05% increase, with the full-year FY2025 number at $93.3 million, up 8.05% from a year prior.
  • Receivables hit $93.3 million in Q4 2025 for Innoviva, roughly flat from $93.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $110.7 million in Q4 2021 to a low of $64.1 million in Q4 2022.
  • Median Receivables over the past 5 years was $84.1 million (2023), compared with a mean of $83.7 million.
  • Biggest five-year swings in Receivables: crashed 42.13% in 2022 and later surged 34.37% in 2024.
  • Innoviva's Receivables stood at $110.7 million in 2021, then crashed by 42.13% to $64.1 million in 2022, then surged by 31.22% to $84.1 million in 2023, then increased by 2.72% to $86.4 million in 2024, then grew by 8.05% to $93.3 million in 2025.
  • The last three reported values for Receivables were $93.3 million (Q4 2025), $93.5 million (Q3 2025), and $88.3 million (Q2 2025) per Business Quant data.